San Diego, CA, United States of America

Pipeline Therapeutics, Inc.


USPTO Granted Patents = 4

% Expired Patents = 50.0

Forward Citations = 11

Loading Chart...
Loading Chart...

13 inventors (with patents filed for the assignee):

goldMedal Yifeng Xiong (2 out of 39 patents)

silverMedal Thomas O Schrader (2 out of 9 patents)

bronzeMedal Jill Melissa Baccei (2 out of 7 patents)

4.  Jeffrey Roger Roppe (2 out of 2 patents)

5.  Yalda Mostofi Bravo (2 out of 20 patents)

6.  Austin Chih-Yu Chen (1 out of 16 patents)

7.  Daniel Scott Lorrain (1 out of 1 patent)

8.  Michael Ming-Yuan Poon (1 out of 1 patent)

9.  Karin Joy Stebbins (1 out of 1 patent)

10.  Thomas Jon Seiders (1 out of 31 patents)

11.  Catherine Yuling Lee (1 out of 2 patents)

12.  Yiwei Li (1 out of 2 patents)

13.  Austin Chen (1 out of 10 patents)


4 patents:

Company Overview
Pipeline Therapeutics is a biopharmaceutical company focused on developing novel therapies for neurological disorders. With a pipeline of innovative drug candidates, Pipeline Therapeutics aims to address significant unmet medical needs in conditions such as Alzheimer's disease, multiple sclerosis, and Parkinson's disease. Through cutting-edge research and strategic partnerships, the company is dedicated to advancing the treatment options available to patients suffering from these debilitating conditions.
Profile summary synthesized from public USPTO records and patent filings.

logo

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

4 Patents

#1,007 in San Diego, CA

#14,051 in California

#60,641 in US

San Diego, CA (US)
San Diego, CA, United States of America
Forward Citations = 11

13 inventors:

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Pipeline Therapeutics, Inc.. Retrieved from https://idiyas.com/company/pipeline-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…